Home

ATP Life Science Ventures, L.P.

CIK 1593440 · last filed 2021-06-30

ATP Life Science Ventures, L.P. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for STOK, was dated Jun 30, 2021. Across all open-market trades the lifetime net is +$108.1M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 11 SEC filings were submitted jointly with ATP III GP, Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

5

Lifetime Open-Market Net

$108.05M

Filer Profile

Reported Address
230 PARK AVENUE, SUITE 2800
NEW YORK, NY 10169
Phone
(212) 468-5800
State of Incorporation
Cayman Islands
Formerly Known As
Apple Tree Partners IV, L.P. (2013–2020)
Related Filers
ATP III GP, Ltd. — 11 joint filings, latest 2021-06-30
Seth Loring Harrison — 4 joint filings, latest 2019-06-19
Cerecor Inc. — 3 joint filings, latest 2016-02-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STOK 10%+ Owner 0 $29.03 $0 $79.25M 3 2021-06-30
Akero Therapeutics, Inc. (AKRO) Delisted 10%+ Owner 0 $54.65 $0 $28.80M 2 2021-06-30

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-06-30 STOK Other (J) −34,323,426 $0 EDGAR
2021-06-30 Akero Therapeutics, Inc. (AKRO) Delisted Other (J) −11,660,406 $0 EDGAR
2020-11-25 STOK Buy (P) +750,000 $29.25M EDGAR
2019-06-25 Akero Therapeutics, Inc. (AKRO) Delisted Mixed +10,830,406 $28.80M EDGAR
2019-06-21 STOK Mixed +33,573,426 $50.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.